These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7128980)

  • 1. [Thalassemic cardiopathy: serial echocardiographic evaluation].
    Bosi S; Spinolo L; Cavallini B; Guadagni C; Lama A; Santarelli R; Baccini C
    G Clin Med; 1982 Apr; 63(4):248-54. PubMed ID: 7128980
    [No Abstract]   [Full Text] [Related]  

  • 2. Subcutaneous desferrioxamine: the effect of three years' treatment on liver, iron, serum ferritin, and comments on echocardiography.
    Flynn DM; Hoffbrand AV; Politis D
    Birth Defects Orig Artic Ser; 1982; 18(7):347-53. PubMed ID: 6819017
    [No Abstract]   [Full Text] [Related]  

  • 3. [Echocardiographic measurements in transfused thalassemic major children].
    Balducci G; Antonelli GF; Mautone A; Di Lecce A; Schettini F
    Minerva Pediatr; 1980 May; 32(9):583-7. PubMed ID: 7464753
    [No Abstract]   [Full Text] [Related]  

  • 4. Medical management of beta-thalassemia.
    Lerner N
    Prog Clin Biol Res; 1989; 309():13-22. PubMed ID: 2780747
    [No Abstract]   [Full Text] [Related]  

  • 5. [Thalassemia major: chelating therapy with deferoxamine].
    Abreu de Miani MS; Sanchis de Herrlein MS; Peñalver JA
    Medicina (B Aires); 1985; 45(3):231-4. PubMed ID: 3841934
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of subcutaneous deferoxamine on the cardiac profile of thalassemia major: a five-year study.
    Giardina PJ; Ehlers KH; Engle MA; Grady RW; Hilgartner MW
    Ann N Y Acad Sci; 1985; 445():282-92. PubMed ID: 3860132
    [No Abstract]   [Full Text] [Related]  

  • 7. [The echocardiography in thalassemia major (author's transl)].
    Musumeci S; Schiliro G; Romeo MA; Di Gregorio F; Russo G; Scibilia G
    Pediatr Med Chir; 1981; 3(2-3):219-22. PubMed ID: 6211659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The echocardiographic characteristics of cardiac lesions in beta-thalassemia].
    Musaev SK; Babaev AA; Dadasheva TS; Nasonova VA
    Revmatologiia (Mosk); 1990; (2):11-7. PubMed ID: 2218258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined subcutaneous and high-dose intravenous deferoxamine therapy of thalassemia.
    Hyman CB; Agness CL; Rodriguez-Funes R; Zednikova M
    Ann N Y Acad Sci; 1985; 445():293-303. PubMed ID: 3860133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac complications in homozygous beta-thalassemia.
    Wonke B; Hoffbrand AV; Aldouri MA; Ward SE
    Prog Clin Biol Res; 1989; 309():51-6. PubMed ID: 2780750
    [No Abstract]   [Full Text] [Related]  

  • 11. [Non-invasive methods of study of the cardiopathy of Cooley's disease].
    Colace F; Antimi M; Tozzi Q; Masi M; Fanfera G; Cecconi M; Cianciulli P; Cipriani C; Stipa E; Pratesi G
    Recenti Prog Med; 1984 Mar; 75(3):241-61. PubMed ID: 6233683
    [No Abstract]   [Full Text] [Related]  

  • 12. Glucose tolerance and chelation therapy in patients with thalassaemia major.
    Capra L; Atti G; De Sanctis V; Candini G
    Haematologica; 1983; 68(1):63-8. PubMed ID: 6404709
    [No Abstract]   [Full Text] [Related]  

  • 13. Quality of life and life expectancy in thalassemic patients with complications.
    Gabutti V; Piga A; Sacchetti L; Sandri A; Biginelli M; Saracco P; Ferri M
    Prog Clin Biol Res; 1989; 309():35-41. PubMed ID: 2780748
    [No Abstract]   [Full Text] [Related]  

  • 14. The cardiac manifestations of thalassemia major: natural history, noninvasive cardiac diagnostic studies and results of cardiac catheterization.
    Ehlers KH; Levin AR; Klein AA; Markenson AL; O'Loughlin JE; Engle MA
    Cardiovasc Clin; 1981; 11(2):171-86. PubMed ID: 7214380
    [No Abstract]   [Full Text] [Related]  

  • 15. Normal serum ferritin levels following prolonged desferrioxamine therapy: Melbourne experience.
    Matthews RN
    Birth Defects Orig Artic Ser; 1988; 23(5B):117-22. PubMed ID: 3390533
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cardiological aspects in thalassemic syndromes in the post-pediatric age: instrumental findings, intracavitary cardiac biopsy reports and autopsy findings].
    Lixi M; Montaldo PL; Satta L; Loddo M; Multineddu R; Fonzo R; Pintus A; Sirigu F; Carcassi U
    Boll Soc Ital Cardiol; 1979; 24(6):637-48. PubMed ID: 551796
    [No Abstract]   [Full Text] [Related]  

  • 17. [Research on the effect of desferrioxamine B in patients with Cooley's disease].
    Silvestroni E; Bianco I; Masi M
    Policlinico Prat; 1967 Dec; 74(50):1681-90. PubMed ID: 4240868
    [No Abstract]   [Full Text] [Related]  

  • 18. Oral ascorbic acid and iron excretion in thalassemic children treated with desferrioxamine-methansulfonate (Desferal).
    Hathirat P; Isarangkura P; Areekul S; Pleehachinda R; Tuntawiroon M
    Birth Defects Orig Artic Ser; 1988; 23(5B):129-33. PubMed ID: 3390535
    [No Abstract]   [Full Text] [Related]  

  • 19. [Role and therapeutic use of deferoxamine in iron overload due to thalassemia (author's transl)].
    Lévy G; Bachelot C; Joannard A; Bost M
    Arch Fr Pediatr; 1980 May; 37(5):299-303. PubMed ID: 7469704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Desferrioxamine-B in the diagnosis of hemosiderotic states and in the therapy of thalassemia. Apropos of 2 cases].
    De Luca G; Faelli U; Petrussa I
    Minerva Pediatr; 1966 Oct; 18(32):1920-5. PubMed ID: 5993655
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.